The experience of key technical personnel who will be responsible for the day-to-day operation: Meharry Principal Investigator: Billy R. Ballard, DDS, MD, is board-certified pathologist. Professor and Chair of the Department of Pathology at Meharry Medical College. Dr. Ballard has more than 40 years experience as a general surgical and cytopathologist with special interest and experts in head and neck, genitourinary, breast, gynecologic, and soft tissue pathology. Dr. Ballard will be responsible for refining the laboratory procedures, hiring personnel, managing the budget, evaluafing and selecting equipment for the laboratory. In addition. Dr. Ballard will be responsible for ensuring the laboratory meets the needs of Partnership investigators. This will be accomplished by interacting closely with the Histopathology Core Internal and External Advisory Committees, which has the responsibility for oversight ofthe core and with the Human Tissue Acquisition and Pathology Core at VICC. The oversight committees will assist with the development and implementation of operational policies and procedures for the core including the development of fee schedules, development and implementation of new procedures or tests, the prioritization and allocation of banked samples, and the selection of pilot studies that to receive fee weavers or a reducfion, and others as the need arises. A close working relationship will be established and maintained to assure that we address the needs of the investigators ufilizing services of the core. An addifional responsibility shall include interacting with principle investigators in developing specific tissue collection protocols available for any technical or scienfific questions concerning tissue procurement. He is responsible for Increasing awareness and availability of this Core the Partnership research community by giving a series of seminars to various groups concerning operafion and services.

National Institute of Health (NIH)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Meharry Medical College
United States
Zip Code
Brown, Shyretha; Whalen, Margaret (2015) Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol 35:895-908
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Sanderson, Maureen; O'Hara, Heather; Foderingham, Nia et al. (2015) Type 2 diabetes and mammographic breast density among underserved women. Cancer Causes Control 26:303-9
Khabele, Dineo; Kabir, Syeda M; Dong, Yuanlin et al. (2014) Preferential effect of akt2-dependent signaling on the cellular viability of ovarian cancer cells in response to EGF. J Cancer 5:670-8
Myers, Jeremy N; Schäffer, Michael W; Korolkova, Olga Y et al. (2014) Implications of the colonic deposition of free hemoglobin-? chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis 20:1530-47
Li, Bo; Lu, Wenfu; Chen, Zhenbang (2014) Regulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less. Receptors Clin Investig 1:
Nangami, Gladys; Koumangoye, Rainelli; Shawn Goodwin, J et al. (2014) Fetuin-A associates with histones intracellularly and shuttles them to exosomes to promote focal adhesion assembly resulting in rapid adhesion and spreading in breast carcinoma cells. Exp Cell Res 328:388-400
Patel, Kushal; Kanu, Mohamed; Liu, Jianguo et al. (2014) Factors influencing breast cancer screening in low-income African Americans in Tennessee. J Community Health 39:943-50
Rekhadevi, P V; Diggs, D L; Huderson, A C et al. (2014) Metabolism of the environmental toxicant benzo(a)pyrene by subcellular fractions of human ovary. Hum Exp Toxicol 33:196-202
Li, Bo; Lu, Wenfu; Yang, Qing et al. (2014) Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer. Prostate 74:421-32

Showing the most recent 10 out of 18 publications